Search results for "rase"

showing 10 items of 4343 documents

Trypanosoma evansi infection in mainland Spain.

2009

An outbreak of Trypanosoma evansi infection that occurred in mainland Spain is described. The outbreak occurred on an equine and camel farm to which dromedary camels from an infected area of the Canary Islands had recently been introduced. One of these camels developed clinical signs and T. evansi was discovered in a blood smear examination. The herd was evaluated in order to determine the extent of the disease. The results showed that 76% of the camels, 35% of the donkeys and 2% of the horses were affected. The animals were isolated and treated using Cymelarsan((R)) (0.5mg/kg). After treatment, three blood analysis using parasitological methods revealed negative results. This is the first …

endocrine systemVeterinary medicineTrypanosomaCamelusAntibodies ProtozoanBiologyCymelarsanPolymerase Chain ReactionArsenicalsDisease OutbreaksSeroepidemiologic StudiesTrypanosomiasisSeroprevalenceAnimalsGeneral VeterinaryOutbreakGeneral MedicineTrypanosoma evansiDNA Protozoanbiology.organism_classificationTrypanocidal AgentsBlood smearParasitologySpainHerdParasitologyMainlandVeterinary parasitology
researchProduct

A common virulence plasmid in biotype 2 Vibrio vulnificus and its dissemination aided by a conjugal plasmid.

2007

ABSTRACT Strains of Vibrio vulnificus , a marine bacterial species pathogenic for humans and eels, are divided into three biotypes, and those virulent for eels are classified as biotype 2. All biotype 2 strains possess one or more plasmids, which have been shown to harbor the biotype 2-specific DNA sequences. In this study we determined the DNA sequences of three biotype 2 plasmids: pR99 (68.4 kbp) in strain CECT4999 and pC4602-1 (56.6 kb) and pC4602-2 (66.9 kb) in strain CECT4602. Plasmid pC4602-2 showed 92% sequence identity with pR99. Curing of pR99 from strain CECT4999 resulted in loss of resistance to eel serum and virulence for eels but had no effect on the virulence for mice, an anim…

endocrine systemanimal structuresCointegrateSequence analysisMolecular Sequence DataVirulenceVibrio vulnificusMicrobiologyPolymerase Chain Reactionlaw.inventionMicrobiologychemistry.chemical_compoundMicePlasmidlawVibrionaceaeAnimalsHumansMolecular BiologyVibrio vulnificusPolymerase chain reactionMolecular Biology of PathogensEelsStrain (chemistry)biologyVirulenceReverse Transcriptase Polymerase Chain ReactionSequence Analysis DNAbiology.organism_classificationBlotting SouthernchemistryConjugation GeneticVibrio InfectionsPlasmidsJournal of bacteriology
researchProduct

Effects of LHRH, progesterone, estradiol-17 ? and dexamethasone in vitro on pineal synaptic ribbons and serotonin N-acetyltransferase activity in die…

1991

Pineal glands of regularly cycling Sprague Dawley rats (180-220 g) killed on the diestrous morning (between 0900-1000 h) were incubated in appropriate media for six hours with LHRH (8.5 microM), progesterone (3.2 microM), estradiol-17 beta (370 nM) or dexamethasone (250 nM). Pineals incubated in hormone-free medium and unincubated glands served as controls. Six rats were used in each group. After incubation the glands were divided into two parts. One part was used to estimate serotonin N-acetyltransferase (NAT) activity. The other part was processed for electron microscopy to quantify synaptic ribbons (SR). The SR numbers were computed to 20,000 microns 2 area of pineal tissue. The number a…

endocrine systemmedicine.medical_specialtyArylamine N-AcetyltransferaseGonadotropin-releasing hormoneBiologyPineal GlandDexamethasonePinealocyteGonadotropin-Releasing HormonePineal glandEstrusInternal medicinemedicineAnimalsProgesteroneBiological PsychiatryDexamethasoneOrganellesEstrous cycleSynaptic ribbonEstradiolRats Inbred StrainsRatsPsychiatry and Mental healthmedicine.anatomical_structureEndocrinologyNeurologyFemaleNeurology (clinical)Serotoninhormones hormone substitutes and hormone antagonistsmedicine.drugEndocrine glandJournal of Neural Transmission
researchProduct

Expression and regulation of mPer1 in immortalized GnRH neurons.

2003

Hypothalamic GnRH (gonadotropin-releasing hormone) neurons play a critical role in the initiation and maintenance of reproduction competence. Using the mouse GnRH neuronal cell line, GT1-7, we have characterized the expression of the gene mPer1, a recognized key element of the mammalian circadian clockwork. Both mPer1 transcripts and the 136 kDa mPER1 gene product could be detected in these cells. Immunocytochemical analysis also confirmed expression of mPER1 both in vitro and in vivo in GnRH neurons. Activation of cyclic AMP signalling pathways in vitro elevated GnRH secretion as well as mPer1 expression and nuclear mPER1 immunoreactivity. As mPER1 is known to feedback on transcriptional a…

endocrine systemmedicine.medical_specialtyCellImmunoblottingCell Cycle ProteinsBiologyGene productGonadotropin-Releasing HormoneMiceInternal medicineGene expressionmedicineAnimalsGeneCells CulturedRegulation of gene expressionNeuronsReverse Transcriptase Polymerase Chain ReactionGeneral NeuroscienceColforsinNuclear ProteinsPeriod Circadian ProteinsImmunohistochemistryPreoptic AreaIn vitromedicine.anatomical_structureEndocrinologyNeuroprotective AgentsGene Expression RegulationCell cultureHypothalamushormones hormone substitutes and hormone antagonistsVasoactive Intestinal PeptideNeuroreport
researchProduct

Absence of mutations in the WT1 gene in patients with XY gonadal dysgenesis

1995

The WT1 gene is normally expressed during gonadal development and specific mutations in heterozygous form cause Drash syndrome, characterized by male pseudohermaphroditism and gonadal dysgenesis, renal failure and a predisposition for Wilms' tumour. These observations prompted us to test whether WT1 mutations are involved in isolated gonadal dysgenesis, being the most severe form of disturbance in gonadal differentiation. We studied 27 cases of 46,XY females with gonadal dysgenesis who had previously been screened for and found not to carry SRY gene mutations. We performed mutational screening of the WT1 gene with denaturing gradient gel electrophoresis. In one of these patients, a heterozy…

endocrine systemmedicine.medical_specialtyGonadGonadal dysgenesisBiologymedicine.disease_causePolymerase Chain ReactionXY gonadal dysgenesisExonInternal medicineGeneticsmedicineHumansGenetics (clinical)Gonadal Dysgenesis 46XYGeneticsMutationurogenital systemPoint mutationDNAExonsmedicine.diseaseEndocrinologymedicine.anatomical_structureTestis determining factorMutationMale pseudohermaphroditismFemaleHuman Genetics
researchProduct

Arylalkylamine N-acetyltransferase gene expression in retina and pineal gland of rats under various photoperiods

2004

Abstract The present study examines how the circadian oscillators in the retina and the suprachiasmatic nucleus (SCN) respond to changes in photoperiod. ArylalkylamineN-acetyltransferase (aa-nat) gene expression studied by quantitative RT-PCR revealed that in adult Sprague–Dawley rats kept under different light–dark (LD) cycles for two weeks the temporal pattern of AA-NAT mRNA expression was identical in retina and pineal gland. In both tissues, the time span between the onset of darkness and the nocturnal rise in AA-NAT mRNA expression was 3 h under LD 20:4, 6 h under LD 12:12, and 15 h under LD 4:20. As aa-nat expression in the pineal gland is regulated by the circadian oscillator in SCN,…

endocrine systemmedicine.medical_specialtyLightArylamine N-AcetyltransferasePhotoperiodCircadian clockBiophysicsGene ExpressionBiologyPineal GlandBiochemistryRetinaRats Sprague-DawleyPineal glandInternal medicineGene expressionmedicineAnimalsRNA MessengerCircadian rhythmMolecular BiologyphotoperiodismSuprachiasmatic nucleusCell BiologyDarknessCircadian RhythmRatsEndocrinologymedicine.anatomical_structureDarknessArylalkylaminesense organsBiochemical and Biophysical Research Communications
researchProduct

Glucagon-like peptide-1 relaxes gastric antrum through nitric oxide in mice.

2010

Abstract Glucagon-like-peptide-1 (GLP-1) is a proglucagon-derived peptide expressed in the intestinal enteroendocrine-L cells and released after meal ingestion. GLP-1 reduces postprandial glycemia not only by its hormonal effects, but also by its inhibitory effects on gastrointestinal motility. Recently, we showed that GLP-1 acts in the enteric nervous system of mouse intestine. Therefore our working hypothesis was that GLP-1 may have also a direct influence on the gastric mechanical activity since the major part of experimental studies about its involvement in the regulation of gastric motility have been conducted in in vivo conditions. The purposes of this study were (i) to examine exogen…

endocrine systemmedicine.medical_specialtyPhysiologyGastric motilityMotilityBiologyNitric OxideBiochemistrySettore BIO/09 - FisiologiaGlucagon-Like Peptide-1 ReceptorNitric oxideMiceCellular and Molecular Neurosciencechemistry.chemical_compoundnitric oxide.EndocrinologyGlucagon-Like Peptide 1Internal medicinePyloric AntrumReceptors GlucagonmedicineAnimalsgastric motilityReceptorAntrumReverse Transcriptase Polymerase Chain ReactionStomachdigestive oral and skin physiologyGlucagon like peptide-1 gastrointestinal hormonemedicine.anatomical_structureEndocrinologychemistryGastrointestinal hormoneEnteric nervous systemGastrointestinal Motilityhormones hormone substitutes and hormone antagonists
researchProduct

Acute selective ablation of rat insulin promoter-expressing (RIP HER ) neurons defines their orexigenic nature

2012

Rat insulin promoter (RIP)-expressing neurons in the hypothalamus control body weight and energy homeostasis. However, genetic approaches to study the role of these neurons have been limited by the fact that RIP expression is predominantly found in pancreatic β-cells, which impedes selective targeting of neurons. To define the function of hypothalamic RIP-expressing neurons, we set out to acutely and selectively eliminate them via diphtheria toxin-mediated ablation. Therefore, the diphtheria toxin receptor transgene was specifically expressed upon RIP-specific Cre recombination using a RIP-Cre line first described by Herrera (RIP HER -Cre) [Herrera PL (2000) Development 127:2317–2322]. Usi…

endocrine systemmedicine.medical_specialtyPituitary glandBiologyReal-Time Polymerase Chain ReactionEnergy homeostasisMiceArcuate nucleusOrexigenicInternal medicineWeight LossmedicineAnimalsInsulinPromoter Regions GeneticDorsomedial hypothalamic nucleusNeuronsDiphtheria toxinMultidisciplinarydigestive oral and skin physiologyArcuate Nucleus of HypothalamusFeeding BehaviorBiological SciencesGlucose Tolerance TestRatsEndocrinologymedicine.anatomical_structurenervous systemHypothalamusNucleushormones hormone substitutes and hormone antagonistsParaventricular Hypothalamic Nucleusmedicine.drugProceedings of the National Academy of Sciences
researchProduct

Mechanisms involved in lipid accumulation and apoptosis induced by 1-nitropyrene in Hepa1c1c7 cells

2011

International audience; 1-Nitropyrene (1-NP) is a nitro-polycyclic aromatic hydrocarbon (nitro-PAH) present in diesel exhaust and bound to particular matter in urban air. We show that 1-NP and the referent PAH benzo(a)pyrene (BP) induce apoptosis and a lipid accumulation dependent on cytochrome P450 1A1-metabolites in mouse hepatoma cells, whereas 1-amino-pyrene had no effect. The caspase inhibitor, N-benzyloxycarbonyl-Val-Ala-Asp(O-Me) fluoromethyl ketone (Z-VAD-fmk), inhibits 1-NP-induced apoptosis, but failed to alter 1-NP-triggered lipid accumulation determined by Nile red staining. We further show that cholesterol and fatty acid contents are modified after nitro-PAH exposure and that 1…

endoplasmic-reticulum stressMESH: PyrenesHepatoma cellsliver-cellsactivated protein-kinaseApoptosisAMP-Activated Protein KinasesToxicologyMESH: Liver Neoplasms ExperimentalMicechemistry.chemical_compoundMESH: CholesterolLiver Neoplasms ExperimentalMESH: AnimalsMESH: AMP-Activated Protein KinasesStearoyl-CoA desaturase 1CaspaseMESH: Lipid Metabolismchemistry.chemical_classificationhuman macrophages0303 health sciencesPyrenesbiology8-tetrachlorodibenzo-p-dioxin tcdd030302 biochemistry & molecular biologyGeneral Medicineinhibition[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry Molecular Biology/Biomolecules [q-bio.BM]CholesterolBiochemistry[SDV.TOX]Life Sciences [q-bio]/ToxicologyCaspaseslipids (amino acids peptides and proteins)stearoyl-coaStearoyl-CoA DesaturaseMESH: Cell Line Tumor[SDV.BC]Life Sciences [q-bio]/Cellular Biology03 medical and health sciencesMESH: Benzo(a)pyreneCell Line Tumor1-NitropyreneBenzo(a)pyreneAnimalsFatty acidsProtein kinase AMESH: Mice030304 developmental biologyaromatic-hydrocarbonsMESH: CaspasesCholesterolMESH: Apoptosisc-srcFatty acidAMPKCytochrome P450Lipid MetabolismMolecular biologychemistryApoptosisMESH: Stearoyl-CoA Desaturasebiology.proteinStearoyl-CoA desaturase-1desaturaseToxicology Letters
researchProduct

In vitro glucuronidation of 7-hydroxycoumarin derivatives in intestine and liver microsomes of Beagle dogs

2019

Beagle dog is a standard animal model for evaluating nonclinical pharmacokinetics of new drug candidates. Glucuronidation in intestine and liver is an important first-pass drug metabolic pathway, especially for phenolic compounds. This study evaluated the glucuronidation characteristics of several 7-hydroxycoumarin derivatives in beagle dog's intestine and liver in vitro. To this end, glucuronidation rates of 7-hydroxycoumarin (compound 1), 7-hydroxy-4-trifluoromethylcoumarin (2), 6-methoxy-7-hydroxycoumarin (3), 7-hydroxy-3-(4-tolyl)coumarin (4), 3-(4-fluorophenyl)coumarin (5), 7-hydroxy-3-(4-hydroxyphenyl)coumarin (6), 7-hydroxy-3-(4-methoxyphenyl)coumarin (7), and 7-hydroxy-3-(1H-1,2,4-t…

entsyymitColonGlucuronidationPharmaceutical Science02 engineering and technologyliver030226 pharmacology & pharmacyBeaglekoira7-hydroxycoumarin derivative03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDogsGlucuronidesPharmacokineticsMicrosomesenzyme kineticsIntestine SmallmedicineAnimalsHumansUmbelliferonesGlucuronosyltransferasekumariinitaineenvaihduntachemistry.chemical_classificationChemistryglucuronidationdog intestinemaksaMetabolismlääkeaineet021001 nanoscience & nanotechnologyCoumarinSmall intestineEnzymemedicine.anatomical_structureBiochemistryLiverfarmakokinetiikkasuolistoMicrosomekoe-eläinmallit0210 nano-technology
researchProduct